A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension

Journal of Human Hypertension

Volumn 16, Issue 8, 2002, Pages 605-610

  James, Ian Gordon V ^a   Jones, A ^b   Davies, P ^c  

^a Spring House Surgery   (United Kingdom)

^b Tal y bont Surgery   (United Kingdom)

^c Cwmfelin Medical Centre   (United Kingdom)

Author keywords

Angiotensin; Dihydropyridine; Lercanidipine; Losartan

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIHYDROPYRIDINE; LERCANIDIPINE; LOSARTAN; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TABLET; TITRIMETRY; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIHYDROPYRIDINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TABLETS;

EID: 0036671429     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001430     Document Type: Article

References (17)

1. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
2. Active dose findings for lercanidipine in a double-blind, placebo-controlled design in patients with mild to moderate hypertension
3. Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension
4. Lercanidipine: Short plasma half-life, long duration of action. A molecular model to rationalize its pharmacokinetic properties
5. Efficacy and tolerability of lercanidipine in comparison to an in combination with atenolol in patients with mild to moderate hypertension in a double-blind controlled study
6. Longterm effects of lercanidipine on the lipoprotein and apolipoprotein profile of patients with mild-to-moderate essential hypertension
7. Efficacy and tolerability of lercanidipine versus captopril in patients with mild to moderate hypertension in a double-blind controlled study
8. Efficacy and tolerability of lercanidipine in patients with mild to moderate essential hypertension: A comparative study with slow-release nifedipine
9. Losartan potassium: A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension
10. Randomised, double-blind, parallel group study of the antihypertensive efficacy and safety to losartan potassium compared with felodipine in elderly patients with mild to moderate hypertension
11. Long-term (12-month) treatment with lercanidipine in patients with mild to moderate hypertension
12. Active dose findings for lercanidipine in a double-blind, placebo-controlled design in patients with mild to moderate hypertension
13. A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension
14. The use of lercanidipine can improve the individual tolerability to dihydropyridine calcium blockers in hypertensive patients
15. Therapeutic efficacy and tolerability of lercanidipine versus candesartan, alone or in combination, in mild-moderate essential hypertensives
16. Comparative evaluation of the antihypertensive efficacy and tolerability of lercanidipine and irbesartan